

![]() |
Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis |
|
Authors | ||
Published in | The Lancet. Psychiatry. 2014, vol. 1, no. 1, p. 55-62 | |
Abstract | Long-term monitoring of white blood cell count is compulsory in patients taking clozapine, although the incidence of drug-induced agranulocytosis is lower than previously expected. The cost-effectiveness of this monitoring is unknown. We aimed to assess the cost-effectiveness of various strategies to monitor white blood cell count in adult patients with schizophrenia taking clozapine. | |
Identifiers | PMID: 26360402 | |
Full text | ||
Structures | ||
Research groups | Epidémiologie clinique (115) Groupe Desmeules Jules (pharmacologie/toxicologie) (567) | |
Citation (ISO format) | GIRARDIN, François et al. Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis. In: The Lancet. Psychiatry, 2014, vol. 1, n° 1, p. 55-62. doi: 10.1016/S2215-0366(14)70245-7 https://archive-ouverte.unige.ch/unige:89789 |